Promega Corporation

CAMK4 Kinase Enzyme System

See All Kinase Enzyme Systems
Recombinant full-length human CAMK4 was expressed by baculovirus in Sf9 insect cells using an N-terminal GST tag. CAMK4 is a multifunctional serine/threonine protein kinase and a member of Ca2+/calmodulin-dependent protein kinase family. CAMK4 is localized in neurons in the hippocampus, amygdala, anterior cingulate cortex, somatosensory cortex and insular cortex. CAMK4 is involved in neural activity-dependent signaling in the neuronal nucleus and thought to play an important role in the consolidation/retention of hippocampus-dependent long-term memory.

ADP-Glo™ Kinase Assay is ...

Expand to Read More »

  • Share
  • Print
  • Email
  • Products
  • Specifications
  • Product Resources
  • Patents & Disclaimers
  • Prices valid for your Promega branch only
Product Size Conc. Catalog # *List Price Order QTY Add to Cart

CAMK4 Kinase Enzyme System

Close Window

CAMK4 Kinase Enzyme System

 Components

10μg
- V2951 $ 381.00 Add to cart

ADP-Glo™ Kinase Assay + CAMK4 Kinase Enzyme System

Close Window

ADP-Glo™ Kinase Assay + CAMK4 Kinase Enzyme System

 Components

  • CAMK4 Kinase Enzyme System

    V29511 x 10μg
  • ADP-Glo™ Kinase Assay

    V91011 x 1,000 assays
1 each
- V9091 $ 758.00 Add to cart


You Also May Be Interested In

Storage Conditions

Upon receipt, centrifuge the kinase and dispense it into smaller quantities. Store the kinase at –70°C and the rest of the components at –20°C.

For product intended use please see Patents & Disclaimers tab.

Use Restrictions

V2951, V9091 For Research Use Only. Not for Use in Diagnostic Procedures.

Patents - Disclaimers

For Cat.# V9091:

Patents Pending.

U.S. Pat. No. 7,700,310 and other patents and patents pending.

U.S. Pat. Nos. 6,602,677, 7,241,584 and 8,030,017 and other patents and patents pending.

U.S. Pat. Nos. 7,083,911, 7,452,663 and 7,732,128 and other patents.

U.S. Pat. No. 7,741,067 and other patents and patents pending.

The method of recombinant expression of Coleoptera luciferase is covered by U.S. Pat. Nos. 5,583,024, 5,674,713 and 5,700,673.

Licensed from Lonza Nottingham Ltd. under U.S. Pat. Nos. 6,599,711 and 6,911,319 and other pending and issued patents.

  • Warning
  • It appears that you have Javascript disabled. Our website requires Javascript to function correctly. Please enable Javascript to experience our website.